MANGOCEUTICALS, INC. Files 8-K Report
Ticker: MGRX · Form: 8-K · Filed: Feb 12, 2025 · CIK: 1938046
| Field | Detail |
|---|---|
| Company | Mangoceuticals, INC. (MGRX) |
| Form Type | 8-K |
| Filed Date | Feb 12, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, sec, corporate-event
TL;DR
MANGOCEUTICALS, INC. filed an 8-K, likely with updates. Check for details.
AI Summary
On February 12, 2025, MANGOCEUTICALS, INC. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial figures or material events beyond the filing itself were detailed in the provided text.
Why It Matters
This 8-K filing indicates that MANGOCEUTICALS, INC. is providing updates or submitting required documentation to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The provided text is a standard 8-K filing notification and does not contain specific financial or operational details that would indicate high risk.
Key Players & Entities
- MANGOCEUTICALS, INC. (company) — Registrant
- February 12, 2025 (date) — Date of Report
- Texas (location) — State of Incorporation
- 001-41615 (other) — SEC File Number
- 87-3841292 (other) — IRS Employer Identification No.
- 15110 N. Dallas Parkway , Suite 600 Dallas , Texas 75248 (address) — Principal executive offices
- (214) 242-9619 (phone_number) — Registrant's telephone number
FAQ
What specific "Other Events" are reported in this 8-K filing?
The provided text does not specify the details of the "Other Events" reported in the 8-K filing.
What is the purpose of filing an 8-K report?
An 8-K report is filed to announce major corporate events that shareholders should know about, such as acquisitions, bankruptcy, or changes in management.
When was this 8-K report filed?
This 8-K report was filed on February 12, 2025.
What is MANGOCEUTICALS, INC.'s state of incorporation?
MANGOCEUTICALS, INC. is incorporated in Texas.
What are the principal executive offices of MANGOCEUTICALS, INC.?
The principal executive offices of MANGOCEUTICALS, INC. are located at 15110 N. Dallas Parkway, Suite 600, Dallas, Texas 75248.
Filing Stats: 852 words · 3 min read · ~3 pages · Grade level 12.2 · Accepted 2025-02-12 08:00:12
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 Par Value Per Share MGRX The Nasdaq
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 27KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- 0001493152-25-006040.txt ( ) — 253KB
- mgrx-20250212.xsd (EX-101.SCH) — 3KB
- mgrx-20250212_lab.xml (EX-101.LAB) — 33KB
- mgrx-20250212_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MANGOCEUTICALS, INC. Date: February 12, 2025 By: /s/ Jacob D. Cohen Jacob D. Cohen Chief Executive Officer